The purpose of the company is to conduct research and development, manufacture, international trade and distribution of products of all kinds, in particular innovative therapeutics for the rejuvenation of the immune system and other products in the biotechnology industry, as well as to provide services related to these products. The company may establish branches and subsidiaries in Switzerland and abroad, take over representations and engage in any business activities and conclude contracts of any kind that may be beneficial to the company's purpose or are directly or indirectly related to the company's purpose. It may acquire, hold, encumber and sell real estate in Switzerland and abroad, except for transactions prohibited by the Federal Act on the Acquisition of Real Estate by Persons Abroad (BewG). In pursuing its corporate purpose, the company may take into account the interests of its direct and indirect shareholders. In particular, the company may grant loans and other direct or indirect financing to its direct and indirect subsidiaries and third parties, including its direct and indirect shareholders and their direct and indirect subsidiaries, including within the framework of cash pooling agreements, and provide security of any kind for their liabilities, including by way of pledges or fiduciary transfers of the company's assets or guarantees of any kind, whether remunerated or not.